A supervisor for the U.S. Customs and Border Protection port of entry in Calais has been accused of illegally swapping out computer parts in his workplace and using them for an online electronic store ...

Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...

In case you've faced some hurdles solving the clue, Modify, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...

A new garden cafe is opening in Greater Boston. Terrain, Anthropologie Group's home and garden lifestyle brand, is officially opening at Wayland Village on Wednesday, Aug. 26 with a retail store, ...

Add The Drive (opens Google in a new window or tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google ...

The 2027 GMC Terrain compact SUV – the sister car of the Chevrolet Equinox – is settling in nicely, three years after its redesign. It comes in three trims with a choice of FWD or AWD and an 8-speed ...

On December 28, 2016, President Obama issued Proclamation 9558, which established the Bears Ears National Monument (Monument) in the State of Utah; reserved approximately 1.35 million acres of Federal ...

Tower Dominion is a unique roguelike tower defense where you build and design the terrain while defending your stronghold against alien invasion. In Tower Dominion, players take on the role of ...

The 2026 GMC Terrain compact SUV enters the second year of its third generation with a broader lineup that gives buyers more choices. After launching in 2025 with only the Elevation trim, GMC now ...

Add The Drive (opens Google in a new window or tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google ...

Kestrel today announced that the first patient has been dosed in its phase 1 trial of KST-6051, an oral small molecule meant to inhibit multiple different kinds of KRAS mutations. (iStock / Getty ...